Matthias Alder - Chief Executive Officer, Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Matthias Alder - trading volume in the past year for Gain Therapeutics, Inc.

Holdings reported by Matthias Alder for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 370,000 $2.17 M $5.86 Mar 21, 2024 Direct Common Stock
Common Stock 21,140 $85.8 K $4.06 Mar 26, 2024 Direct
Restricted Stock Units 6,376 $24.6 K $3.86 Mar 26, 2024 Direct Common Stock

Transactions reported by Matthias Alder for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership